2006
DOI: 10.1097/01.hco.0000245735.55335.d9
|View full text |Cite
|
Sign up to set email alerts
|

Off-pump coronary artery bypass grafting through sternotomy: for whom?

Abstract: Though every patient must be dealt with on an individual basis, it would appear that almost any patient is a candidate for off-pump coronary artery bypass and that, given time and an appropriate desire, most any surgeon can perform the procedure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
3
0

Year Published

2009
2009
2010
2010

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
1
3
0
Order By: Relevance
“…6,20 OPCAB also improved mortality, morbidity, and resource utilization compared to on-pump CABG in high-risk patients. 6,20 Our results are consistent with these studies. Our volume of OPCAB reached a plateau over these 5 years.…”
Section: Discussionsupporting
confidence: 95%
See 2 more Smart Citations
“…6,20 OPCAB also improved mortality, morbidity, and resource utilization compared to on-pump CABG in high-risk patients. 6,20 Our results are consistent with these studies. Our volume of OPCAB reached a plateau over these 5 years.…”
Section: Discussionsupporting
confidence: 95%
“…20 In recent years, OPCAB has demonstrated better shortterm outcomes in terms of atrial fibrillation, blood transfusion, and length of hospital stay in mixed-risk patient populations. 6,20 OPCAB also improved mortality, morbidity, and resource utilization compared to on-pump CABG in high-risk patients. 6,20 Our results are consistent with these studies.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…10 OPCAB has been shown to be beneficial for patients at increased risk of stroke, diabetic patients, and women. [11][12][13][14][15] In particular, we have previously demonstrated a significant early mortality and morbidity advantages for women and equal 10-year survival compared with men. 12 Specifically, among OPCAB patients, we have previously reported the mitigation of adverse events and equalization of outcomes in women compared with men.…”
mentioning
confidence: 99%